Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Extra chemo step tested to stop esophageal Cancer's spread

NCT ID NCT03110926

Summary

This study is testing whether adding a specific chemotherapy regimen (mFOLFOX6) before the usual treatment plan can help prevent esophageal cancer from spreading to other parts of the body. It involves 40 adults with locally advanced esophageal cancer who can still have surgery. The goal is to see if this extra step improves survival and keeps the cancer from returning.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Rochester

    Rochester, New York, 14642, United States

Conditions

Explore the condition pages connected to this study.